SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Advanced Cell Technology Announces Aberdeen University Royal Infirmary in Scotland as Additional Site for Phase 1/2 Clinical Trial Using hESC-Derived RPE Cells for Macular Degeneration